Familial hypercholesterolaemia Flashcards
mechanisms of lipid transport to tissues of VLDL -> LDL
- VLDL exits liver then converted to IDL -> LDL
- LDL: B100 binds to LDL receptor on peripheral cells = uptake OR (70%) binds to liver = uptake
* if LDL receptor defect = accumulation of LDL
Familial Hypercholesterolaemia-what it is? (pathophysiology)
LDL primarily elevated due to LDL-receptor mutations or Apo B100 mutation = less uptake of LDL in liver & tissues = LDL accumulate in blood => tiss. lipid deposition in BV wall
factors that cause of hyperlipidaemia
- Genetics: primary cause
- poly genenic: effect of multiple genes & environmental/behavioural influences (diet/excercise)
- secondary cause: other disorders e.g. hypothyroidism, alcohol, diabietes, renal failure
Examples of founder effects, and approach/consequences for molecular diagnosis
certain mutations commonly found in Certain popu. e.g.
- Afrikaner: 3 founder mutations
- Christian Lebanese: 10x homozygous freq
- French Canadians: 5 founder mutations
Risk factors for CVD/coronary <3 disease
- Age, Sex, family Hx
- smoking, hyperlipidaemia, BMI, diabetes (modifiable RF)
Type of lipoproteins & they function
- LDL & HDL > transports cholesterol to & from peripheral tiss
- VLDL > transports TG to peripheral tiss -> LDL
- Chylomicrons > similar func as VLDL
- IDL > intermediate for VLDL to LDL
- Chylomicron remnants > carry TG & cholesterol
What are apolipoprotein (apo) & function?
- proteins assoc w/ lipoprotein particles
> mediate Binding of lipoprotein to protein receptors
> required for synthesis of lipoproteins
> co-factors for enz involved in metabolism & remodelling of lipoprotein
e.g. of Binding of lipoprotein to protein receptors
a) Apo B-100
b) Apo E-ligand
c) Apo A1 ligand
a) Apo B-100: (on LDL) binds to LDL receptor
b) Apo E-ligand: (on VLDL, chilomicron remnants) binds to LDL receptor
c) Apo A1 ligand: (on HDL) binds to ABCA1 receptor
Genetics of FH
a) inheritance pattern
b) molecular genetics
c) mutation spectrum
a) autosomal dominant disorder (can be co-dominant) *homoz: severely affected
b) mostly LDLReceptor defect, some due to mutations in apo B-100 or PCSK9
c) wide mutation spectrum bc >1000 LDLR mutations
What tests fall under the cascade testing for FH
- measure lipid levels
- genetic testing: by NGS then Sanger seq then MLPA OR by using Kits e.g. ARMS, reverse hybridization